Association of PC and AT levels in the early phase of STEMI treated with pPCI with LV systolic function and 6-month MACE

References

• Walker FJ. Regulation of activated protein C by a new protein: a possible function for bovine protein S. J Biol Chem. 1980;255(12):5521–5524.
   Google Scholar
• Danese S, Vetrano S, Zhang L, et al. The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications. Blood. 2010;115(6):1121–1130.
   Google Scholar
• Taylor FB, Lockhart MS. A new function for activated protein C: activated protein C prevents inhibition of plasminogen activators by releasate from mononuclear leukocytes-platelet suspensions stimulated by phorbol diester. Thromb Res. 1985;37(1):639–649.
   Google Scholar
• High KA. Antithrombin III, protein C, and protein S. Naturally occurring anticoagulant proteins. Arch Pathol Lab Med. 1988 Jan;112(1):28–36.
   Google Scholar
• Liumbruno G, Bennardello F, Lattanzio A. Italian society of transfusion medicine and immunohaematology (SIMTI) working party. Recommendations for the use of antithrombin concentrates and prothrombin complex concentrates. Blood Transfus. 2009;7(4):325–334.
   Google Scholar
• Soare AM, Popa C. Deficiencies of proteins C, S and antithrombin and activated protein C resistance–their involvement in the occurrence of arterial thromboses. J Med Life. 2010;3(4):412–415.
   Google Scholar
• Boekholdt SM, Kramer MH. Arterial thrombosis and the role of thrombophilia. Semin Thromb Hemost. 2007;33:588–596.
   Google Scholar
• Vossen CY, Rosendaal FR. Risk of arterial thrombosis in carriers of familial thrombophilia. J Thromb Haemeos. 2006;4:916–918.
   Google Scholar
• Zorio E, Navarro S, Medina P. Circulating activated protein C is reduced in young survivors of myocardial infarction and inversely correlates with the severity of coronary lesions. J ThrombHaemeos. 2006;4:1530–1536.
   Google Scholar
• Simioni P, Zanardi S, Saracino A. Occurrence of arterial thrombosis in a cohort of patients with hereditary deficiency of clotting inhibitors. J Med. 1992;23:61–74.
   Google Scholar
• Folsom AR, Rosamond WD, Shahar E, et al. Prospective study of markers of hemostatic function with risk of ischemic stroke: the Atherosclerosis risk in communities (ARIC) study investigators. Circulation. 1999;100:736–742.
   Google Scholar
• Swiatkiewicz I, Kozinski M, Magielski P, et al. Value of C-reactive protein in predicting left ventricular remodeling in patients with a first ST-segment elevation myocardial infarction. Mediators Inflamm. 2012;2012:250867.
   Google Scholar
• Tiong IY, Alkotob ML, Ghaffari S. Protein C deficiency manifesting as an acute myocardial infarction and ischaemic stroke. Heart. 2003;89(2):E7.
   Google Scholar
• Kumar A, Cannon CP. Acute coronary syndromes: diagnosis and management, part I. Mayo Clin Proc. 2009;84(10):917–938.
   Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) task force for the universal definition of myocardial infarction. J Am Coll Cardiol. 2018;72(18):2231.
   Google Scholar
• Bahall M, Seemungal T, Legall G. Risk factors for first-time acute myocardial infarction patients in Trinidad. BMC Public Health. 2018;18(1):161.
   Google Scholar
• Laszik Z, Carson CW, Nadasdy T, et al. Lack of suppressed renal thrombomodulin expression in a septic rat model with glomerular thrombotic microangiopathy. Lab Invest. 1994;70(6):862–867.
   Google Scholar
• Rezaie AR. Regulation of the protein C anticoagulant and antiinflammatory pathways. Curr Med Chem. 2010;17(19):2059–2069.
   Google Scholar
• Cheng T, Petraglia AL, Li Z, et al. Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage. Nat Med. 2006;12(11):1278–1285.
   Google Scholar
• Zakai NA, Judd SE, Kissela B, et al. Factor VIII, protein C and cardiovascular disease risk: the reasons for geographic and racial differences in stroke study (REGARDS). Thromb Haemost. 2018;118(7):1305–1315.
   Google Scholar
• Callas PW, Tracy RP, Bovill EG, et al. The association of anticoagulant protein concentrations with acute myocardial infarction in the thrombolysis in myocardial infarction phase II (TIMI II) trial. J Thromb Thrombolysis. 1998;5(1):53–60.
   Google Scholar
• Folsom AR, Aleksic N, Wang L, et al. Protein C, antithrombin, and venous thromboembolism incidence: a prospective population-based study. Arterioscler Thromb Vasc Biol. 2002;22(6):1018–1022.
   Google Scholar
• Folsom AR, Ohira T, Yamagishi K, et al. Low protein C and incidence of ischemic stroke and coronary heart disease: the Atherosclerosis risk in communities (ARIC) study. J Thromb Haemost. 2009;7(11):1774–1778.
   Google Scholar
• Stankovic S, Obradovic S, Dzudovic B, et al. Lower plasma protein C activity is associated with early myocardial necrosis and no-reflow phenomenon in patients with ST elevation myocardial infarction. Acta Cardiol. 2019;74(4):331–339.
   Google Scholar
• Maehata Y, Miyagawa S, Sawa Y. Activated protein C has a protective effect against myocardial I/R injury by improvement of endothelial function and activation of AKT1. PLoS One. 2012;7:e38738.
   Google Scholar
• Sakamoto T, Ogawa H, Takazoe K, et al. Effect of activated protein C on plasma plasminogen activator inhibitor activity in patients with acute myocardial infarction treated with alteplase. Comparison with unfractionated heparin. J Am Coll Cardiol. 2003;42:1389–1394.
   Google Scholar
• Fennich N, Salwa A, Nadia B, et al. Acute coronary syndrome in a young woman with antithrombin III deficiency. J Cardiol Cases. 2013;7(4):e101–e103.
   Google Scholar
• Von Kaulla E, Von Kaulla KN. Oral contraceptives and low antithrombin-III activity. Lancet. 1970;295:36.
   Google Scholar
• Fortin CJ, Klein T, Messmore HL, et al. Myocardial infarction and severe thromboembolic complications. As seen in an estrogen-dependent transsexual. Arch Intern Med. 1984;144:1082–1083.
   Google Scholar
• Peovska I, Maksimovic J, Kalpak O, et al. Recurrent myocardial infarction in a young football player with antithrombin III deficiency. Cardiol J. 2008;15:463–466.
   Google Scholar
• Gorog DA, Rakhit R, Parums D, et al. Raised factor VIII is associated with coronary thrombotic events. Heart. 1998;80(4):415–417.
   Google Scholar